Noushin Farnoud
- Hematology top 2%
- Acute Myeloid Leukemia Research 15
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 2
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 14
-
- RNA Interference and Gene Delivery 2
-
- Eosinophilic Disorders and Syndromes 2
-
- Acute Lymphoblastic Leukemia research 2
-
- CAR-T cell therapy research 2
- Co-authors
- Martin S. TallmanElli PapaemmanuilRoss L. LevineKatharine YenAlan H. ShihBin WuVirginie Penard‐LacroniqueBenoît Marteyn
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Noushin Farnoud
20 papers receiving 721 citations
Peers
Comparison fields: 5 of 45
- Hematology 520
- Genetics 208
- Molecular Biology 477
- Cancer Research 104
- Rheumatology 50
Countries citing papers authored by Noushin Farnoud
This map shows the geographic impact of Noushin Farnoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noushin Farnoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noushin Farnoud more than expected).
Fields of papers citing papers by Noushin Farnoud
This network shows the impact of papers produced by Noushin Farnoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noushin Farnoud. The network helps show where Noushin Farnoud may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noushin Farnoud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 26 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 0 | |
| 10 | 2019 | 2 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 35 | |
| 13 | 2018 | 39 | |
| 14 | 2018 | 39 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 249 | |
| 17 | 2016 | 166 | |
| 18 | 2014 | 3 | |
| 19 | 2013 | 1 | |
| 20 | 2008 | 63 |
About Noushin Farnoud
Noushin Farnoud is a scholar working on Hematology, Genetics and Cancer Research, having authored 22 papers that have together received 723 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (7 papers), Acute Lymphoblastic Leukemia research (2 papers), CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Hematology (520 citations), Genetics (208 citations) and Molecular Biology (477 citations). Noushin Farnoud has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Martin S. Tallman, Elli Papaemmanuil, Ross L. Levine, Katharine Yen, Alan H. Shih, Bin Wu, Virginie Penard‐Lacronique, Benoît Marteyn, Paresh Vyas and Michael Amatangelo. Their work appears in journals such as Nucleic Acids Research, Blood and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.